PLA2R1 and adrenomyeloneuropathy: However, there have been few reports of antigens/antibodies to aMN, previous study in our center suggested no difference in anti-PLA2R antibody positive rates between aMN and iMN patients (57.4 % vs. 48.1 %, p = 0.168)[7], which suggests that aMN and iMN may be the same disease in essence.